Hemispherian

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

Glionova AB

Glionova AB develops orally available oncolytic small molecules to treat glioblastoma and other aggressive cancers for patients with high unmet medical needs.

Dania Therapeutics

The company develops small-molecule therapies targeting cancer metabolism to treat acute myeloid leukaemia and other life-threatening cancers for medical patients.

Apexian Pharmaceuticals

This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.

Calithera

This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.